Inhibition of IRE1?-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia

by Sun, H, Lin, D.-C, Guo, X, Masouleh, B.K, Gery, S, Cao, Q, Alkan, S, Ikezoe, T, Akiba, C, Paquette, R, Chien, W, Müller-Tidow, C, Jing, Y, Agelopoulos, K, Müschen, M, Koeffler, H.P
Published 2020

BCL6 is critical for the development of a diverse primary B cell repertoire

by Duy, C., Nahar, R., Swaminathan, S., Kweon, S.-M., Klemm, L., Shojaee, S., Hurtz, C., Ramezani-Rad, P., Muschen, M., Duy, C., Nahar, R., Swaminathan, S., Kweon, S.-M., Klemm, L., Shojaee, S., Hurtz, C., Ramezani-Rad, P., Muschen, M., Duy, C., Yu, J.J., Ye, B.H., Polo, J.M., Polo, J.M., Valls, E., Cerchietti, L., Melnick, A.M., Valls, E., Cerchietti, L., Melnick, A.M., Schuh, W., Jack, H.-M., Herzog, S., Jumaa, H., Koeffler, H.P., De, Alboran I.M.
Published 2011

SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations

by Nowak, D., Ogawa, S., Müschen, M., Kato, M., Kawamata, N., Meixel, A., Nowak, V., Kim, H.S., Kang, S., Paquette, R., Chang, M.-S., Thoenissen, N.H., Mossner, M., Hofmann, W.-K., Kohlmann, A., Weiss, T., Haferlach, T., Haferlach, C., Phillip Koeffler, H.
Published 2016